Exercise, Kidney Transplantation
Conditions
Brief summary
Evaluate the effectiveness of a Whole body vibration training program on quadriceps muscle strength, functional capacity and respiratory muscle strength in adult renal transplant recipients
Detailed description
The study will be a randomized controlled clinical trial involving adult renal transplant recipients, who will be recruited through eligibility criteria at Nephrology outpatient clinics of the Kidney Transplantation Centers of the Hospital das Clínicas of the Federal University of Pernambuco (HC-UFPE). Individuals will be randomized and assigned to one of the following groups: Platform Group, which will perform 12-week whole body vibration training or Platform SHAM Group that will receive treatment without the therapeutic effect of the platform. Afterwards, the patients will be submitted to an evaluation, a form with sociodemographic data, the clinical history of the disease and the laboratory tests will be completed, after which the pulmonary function, respiratory muscle strength, quadriceps muscle strength and thickness, postural balance , Functional capacity, quality of life, risk of falls and level of physical activity.
Interventions
Whole body vibration training will consist of 12 consecutive weeks with two sessions per week on alternate days. Initially, before training with the vibratory platform, stretches lasting 5 to 10 minutes will be performed, with a series of 60 seconds for each of the following muscle groups: pectorals, sternocleidomastoids, scalenes, quadriceps and ischiatibial muscles. Patients will be monitored through vital signs for follow-up.
will receive the treatment without the therapeutic effect of the platform, but with vibrating platform connected with the display lit and a sound device coupled with a noise recording generated by the vibration, but without therapeutic purposes.
Sponsors
Study design
Eligibility
Inclusion criteria
* patients with more than 1 year of kidney transplant surgery * stable graft function (creatinine \<1.8 mg / dL) * hemoglobin\> 8g / dL * age range 18 And 59 * both sexes
Exclusion criteria
* PAS\> 160mmHg and PAD\> 100mmHg * Patients with neurological, diagnosed or pulmonary heart disease * Involved in some physiotherapeutic program * With hospitalization history for 3 months * Pregnant * Current or previous smokers * That use pacemaker, screws and / or pins in the body * Presence of acute migraines, labyrinthitis * History of thrombosis * Body weight greater than 120Kg * Cognitive, visual and / or auditory deficits * Osteomioarticular diseases that would impair evaluation procedures and / or training
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Quadriceps muscle strength | 20 minutes | Will be performed the examination of the Maximum Voluntary Isometric Contraction |
| Functional capacity | 10 minutes | The 6-minute walk test will be used |
| Respiratory muscle strength | 20 minutes | Will be performed through the manocacuometry with the evaluation of the maximum respiratory pressures |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Risk of fall | 5 minutes | The International Fall Efficiency Scale (FES-I) will be used |
| Thickness of the quadriceps | 10 minutes | This measure will be obtained through the portable Ultrasound |
| Quality of life | 10 minutes | Will be applied the Medical Outcomes Study Quality of Life Questionnaire - Short-Form Health Survey |
| Level of physical activity | 5 minutes | It will be evaluated by the International Physical Activity Questionnaire |
| Postural balance | 20 minutes | The static and dynamic postural balance will be evaluated through the Biodex Balance System |
| Pulmonary function | 15 minutes | Slow and forced spirometry will be used |
Countries
Brazil